The Goldman Sachs Group Upgrades Versigent (NYSE:VGNT) to “Strong-Buy”

Versigent (NYSE:VGNT) was upgraded by equities research analysts at The Goldman Sachs Group to a “strong-buy” rating in a note issued to investors on Monday,Zacks.com reports.

A number of other equities research analysts have also recently issued reports on VGNT. Zacks Research upgraded Versigent from a “hold” rating to a “strong-buy” rating in a research note on Thursday, July 2nd. Royal Bank Of Canada raised their target price on shares of Versigent from $34.00 to $41.00 and gave the company a “sector perform” rating in a research note on Monday, July 13th. TD Cowen boosted their target price on shares of Versigent from $47.00 to $49.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. BNP Paribas Exane began coverage on shares of Versigent in a research report on Tuesday, April 28th. They set an “outperform” rating and a $41.00 price target on the stock. Finally, Evercore reiterated an “outperform” rating and issued a $60.00 price target on shares of Versigent in a research note on Monday, May 18th. Three research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat, Versigent presently has a consensus rating of “Buy” and an average target price of $49.60.

Versigent Stock Down 0.1%

Shares of NYSE VGNT opened at $39.97 on Monday. The company’s 50 day moving average is $43.46. Versigent has a 52 week low of $26.34 and a 52 week high of $50.88.